6-(3-(4-Fluorobenzyloxy)phenyl)-5-phenylimidazo[2,1-b]thiazole

ID: ALA4860667

PubChem CID: 163409284

Max Phase: Preclinical

Molecular Formula: C24H17FN2OS

Molecular Weight: 400.48

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Fc1ccc(COc2cccc(-c3nc4sccn4c3-c3ccccc3)c2)cc1

Standard InChI:  InChI=1S/C24H17FN2OS/c25-20-11-9-17(10-12-20)16-28-21-8-4-7-19(15-21)22-23(18-5-2-1-3-6-18)27-13-14-29-24(27)26-22/h1-15H,16H2

Standard InChI Key:  LGKXVQVZFJBDLT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   21.7747  -22.7542    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.9901  -23.0114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9901  -23.8363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7747  -24.0934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2594  -23.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2053  -22.7542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7206  -23.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2053  -24.0934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2484  -26.2749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5055  -25.4903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9524  -24.8780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1423  -25.0463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8893  -25.8309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4424  -26.4473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8956  -23.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4831  -24.1396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6581  -24.1396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2456  -23.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6581  -22.7121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4831  -22.7121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2456  -24.8514    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.4206  -24.8499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0070  -25.5637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1824  -25.5608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7688  -26.2737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1801  -26.9898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0095  -26.9886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4193  -26.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7674  -27.7041    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  1  5  1  0
  6  7  1  0
  7  8  2  0
  2  6  2  0
  3  8  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  9 14  2  0
  8 11  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 15 20  2  0
 17 21  1  0
  7 15  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4860667

    ---

Associated Targets(Human)

Panel NCI-60 (60 carcinoma cell lines) (1088 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 400.48Molecular Weight (Monoisotopic): 400.1046AlogP: 6.45#Rotatable Bonds: 5
Polar Surface Area: 26.53Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.31CX LogP: 6.10CX LogD: 6.10
Aromatic Rings: 5Heavy Atoms: 29QED Weighted: 0.34Np Likeness Score: -1.67

References

1. Zaraei SO, Sbenati RM, Alach NN, Anbar HS, El-Gamal R, Tarazi H, Shehata MK, Abdel-Maksoud MS, Oh CH, El-Gamal MI..  (2021)  Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors.,  224  [PMID:34237622] [10.1016/j.ejmech.2021.113674]

Source